In our case series, Patient 2 developed diabetes following weight regain during the temporary GLP-1 RA treatment discontinuation and semaglutide was successful in weight control before and after the onset of diabetes
GIP enhances the first phase of insulin release, while GLP-1 sustains the second phase
Given this is an area of active research, more studies are needed to fully elucidate the impact of G6PD-d on VSMCs in atherosclerosis
Cost of Oral vs Injectable and Other Therapies No new drug adoption is possible without the proper cost-related analysis in relation to already available options
Tirzepatide (a dual GLP-1/GIP agonist) achieves 15-22% weight reduction
(There are, however, a range of options available to you if you consult with a Midi clinician about your weight concerns proven medications that can help, and you will be carefully guided through your options.) Safety Reality Check: Scams, Counterfeits, and Research Use Products If youre browsing online and come across GLP-1 patches, there are some common red flags to watch for
